South San Francisco, CA, November 7, 2023 – Media Release DEPARTURE OF ALEXANDER HARDY & APPOINTMENT OF ASHLEY MAGARGEE AS INTERIM CHIEF EXECUTIVE OFFICER GENENTECH South San Francisco, CA — November 1st, 2023 — Alexander Hardy, Chief Executive Officer of…
May 10th, 2023 – South San Francisco, CA – Genetech Press Release Acceptance based on two Phase III studies that demonstrated early and sustained vision improvement with Vabysmo, meeting primary endpoint of non-inferiority compared to aflibercept Application was further supported…
February 9th, 2023 – South San Francisco, CA Genetech Press Release New Phase III Data Show Genentech’s Vabysmo Rapidly Improved Vision and Reduced Retinal Fluid in People With Retinal Vein Occlusion (RVO) Vabysmo met its primary endpoint in two clinical…
South San Francisco, CA – December 22nd, 2022 FDA Approves Genentech’s Actemra for the Treatment of COVID-19 in Hospitalized Adults Actemra is the first FDA-approved monoclonal antibody to treat COVID-19 Since the beginning of the pandemic, more than one million…